Bicarbonate

Bicarbonate

SCHEMBL2810754

O=C([O-])[O-].[Hg+]c1ccccc1.[Hg+]c1ccccc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.50
CA4 P22748 2/20 0.50
CES1 P23141 4/20 0.43
CES2 O00748 3/20 0.43
ALDH1A1 P00352 3/20 0.43
TSHR P16473 3/20 0.43
ALOX15 P16050 2/20 0.43
DAO P14920 1/20 0.43
NAPRT Q6XQN6 1/20 0.43
POLB P06746 2/20 0.40
ALPL P05186 1/20 0.40
ALPG P10696 1/20 0.40
CYP3A4 P08684 2/20 0.39
MAPT P10636 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
PARP1 P09874 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL49139 0.88 CA2 (0.46) CA2CA4CES1CES2ALDH1A1
Acetic Acid SCHEMBL12613566 0.86 CA2 (0.44) CA2CA4CES1CES2ALDH1A1
Acetic Acid SCHEMBL9450967 0.84 CA2 (0.42) CA2CA4CES1CES2ALDH1A1
Fumaric Acid SCHEMBL11588378 0.84 CA2 (0.42) CA2CA4CES1CES2ALDH1A1
Benzoic Acid SCHEMBL2808746 0.84 CA2 (0.76) CA2CA4CES1CES2ALDH1A1
Succinic Acid SCHEMBL11308652 0.84 HDAC3 (0.52) CA2CA4CES1CES2ALDH1A1
Propionic Acid SCHEMBL448138 0.82 CES2 (0.50) CA2CA4CES1CES2ALDH1A1
Trifluoroacetic Acid SCHEMBL10946380 0.82 CES1 (0.48) CA2CA4CES1CES2TDP1
Methacrylic Acid SCHEMBL10896945 0.80 ALDH1A1 (0.47) CA2CA4CES1CES2ALDH1A1
Acetic Acid SCHEMBL4148336 0.80 ALDH1A1 (0.46) CA2CA4CES1CES2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2207416-B1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM IMERYS FILTRATION MINERALS INC (US) 2018-11-07 EP disclosed
US-20100239679-A1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM WORLD MINERALS, INC. (US) 2010-09-23 US disclosed
US-20060276339-A1 Methods and compositions for increasing the efficacy of biologically-active ingredients BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276339-A1 Methods and compositions for increasing the efficacy of biologically-active ingredients ENPP1, ENPP3, SMPD1 CA2 460/4885CA4 1012/4885CES1 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.